Canada markets close in 2 hours 58 minutes

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.87-3.97 (-8.30%)
As of 01:02PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.80B
Enterprise Value 5.56B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)14.32
Price/Book (mrq)29.83
Enterprise Value/Revenue 14.03
Enterprise Value/EBITDA -11.23

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 3-42.46%
S&P500 52-Week Change 324.19%
52 Week High 394.75
52 Week Low 319.83
50-Day Moving Average 357.62
200-Day Moving Average 351.26

Share Statistics

Avg Vol (3 month) 31.32M
Avg Vol (10 day) 31.23M
Shares Outstanding 5120.58M
Implied Shares Outstanding 6121.29M
Float 881.27M
% Held by Insiders 113.14%
% Held by Institutions 195.42%
Shares Short (Apr 15, 2024) 410.67M
Short Ratio (Apr 15, 2024) 49.39
Short % of Float (Apr 15, 2024) 410.27%
Short % of Shares Outstanding (Apr 15, 2024) 48.85%
Shares Short (prior month Mar 15, 2024) 410.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -133.29%
Operating Margin (ttm)-57.74%

Management Effectiveness

Return on Assets (ttm)-41.73%
Return on Equity (ttm)-290.14%

Income Statement

Revenue (ttm)396.59M
Revenue Per Share (ttm)3.34
Quarterly Revenue Growth (yoy)545.90%
Gross Profit (ttm)N/A
EBITDA -515.34M
Net Income Avi to Common (ttm)-528.63M
Diluted EPS (ttm)-4.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)355.54M
Total Cash Per Share (mrq)2.95
Total Debt (mrq)110.93M
Total Debt/Equity (mrq)57.03%
Current Ratio (mrq)3.10
Book Value Per Share (mrq)1.63

Cash Flow Statement

Operating Cash Flow (ttm)-594.73M
Levered Free Cash Flow (ttm)-404.84M